These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Facile fully automated radiosynthesis and quality control of O-(2-[ Wang M; Glick-Wilson BE; Zheng QH Appl Radiat Isot; 2019 Dec; 154():108852. PubMed ID: 31442794 [TBL] [Abstract][Full Text] [Related]
25. Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas. Stegmayr C; Schöneck M; Oliveira D; Willuweit A; Filss C; Galldiks N; Shah NJ; Coenen HH; Langen KJ Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1115-23. PubMed ID: 26646781 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of novel F-18 labeled fluoroarylvaline derivatives: potential PET imaging agents for tumor detection. Qiao Y; He Y; Zhang S; Li G; Liu H; Xu J; Wang X; Qi C; Peng C Bioorg Med Chem Lett; 2009 Aug; 19(16):4873-7. PubMed ID: 19616943 [TBL] [Abstract][Full Text] [Related]
27. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290 [TBL] [Abstract][Full Text] [Related]
28. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
29. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma. Gandia P; Jaudet C; Everaert H; Heemskerk J; Vanbinst AM; de Mey J; Duerinck J; Neyns B; de Ridder M; Chatelut E; Concordet D Clin Pharmacokinet; 2017 Aug; 56(8):953-961. PubMed ID: 27995528 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. Wester HJ; Herz M; Weber W; Heiss P; Senekowitsch-Schmidtke R; Schwaiger M; Stöcklin G J Nucl Med; 1999 Jan; 40(1):205-12. PubMed ID: 9935078 [TBL] [Abstract][Full Text] [Related]
31. Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats. Lee TS; Ahn SH; Moon BS; Chun KS; Kang JH; Cheon GJ; Choi CW; Lim SM Nucl Med Biol; 2009 Aug; 36(6):681-6. PubMed ID: 19647174 [TBL] [Abstract][Full Text] [Related]
32. [Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent]. Dang YH; Wang SZ; Cheng X; Zhou Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):370-2. PubMed ID: 12905655 [TBL] [Abstract][Full Text] [Related]
33. O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results. Stegmayr C; Willuweit A; Lohmann P; Langen KJ Curr Radiopharm; 2019; 12(3):201-210. PubMed ID: 30636621 [TBL] [Abstract][Full Text] [Related]
34. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain. Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835 [TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]